Jason B. Daly - Nov 15, 2024 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
SVP, Chief Legal Officer
Signature
/s/ Denis Butkovic, Attorney-in-Fact
Stock symbol
AMRX
Transactions as of
Nov 15, 2024
Transactions value $
-$375,887
Form type
4
Date filed
11/19/2024, 04:17 PM
Previous filing
Mar 5, 2024
Next filing
Nov 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Sale -$376K -43.7K -76.16% $8.61 13.7K Nov 15, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.50 to $9.00 per share, inclusive. The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.